The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced melanoma: Safety and efficacy results from a phase I study.
 
Yu Chen
No Relationships to Disclose
 
Jing Lin
No Relationships to Disclose
 
Hui Wang
No Relationships to Disclose
 
Weizhen Zhang
No Relationships to Disclose
 
Xinjun Liang
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Meiyu Fang
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Qian Chu
No Relationships to Disclose
 
Xueli Bai
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Xiaoshi Zhang
No Relationships to Disclose
 
Li Zhao
Employment - Innovent Biologics
 
Haonan Chen
Employment - Innovent Biologics
 
Hongli Wang
Employment - Innovent Biologics
 
Yuling Chen
Employment - Innovent Biologics
 
Xing Sun
Employment - Innovent Biologics
 
Hui Zhou
Employment - Innovent Biologics